JAZZ PHARMACEUTICALS, INC.

Lobbying client · California · filed 2025 to 2026

$2,610,000 Reported spend

6 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (210180), not by name.

Firms hired 1

JAZZ PHARMACEUTICALS, INC. $2,610,000 6 filings

Bills named in these filings 1

HR 946
ORPHAN Cures Act

6 filings

Reported by year 2 years

2026 $960,000 2 filings
2025 $1,650,000 4 filings

Issues lobbied 1

Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

Food & Drug Administration (FDA) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Office of Management & Budget (OMB) 1
Treasury, Dept of 1
White House Office 1

Recent filings 6 total

Q2

JAZZ PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $490,000 expenses · posted Jul 20, 2026

View → Q1

JAZZ PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $470,000 expenses · posted Apr 20, 2026

View → Q4

JAZZ PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $490,000 expenses · posted Jan 16, 2026

View → Q3

JAZZ PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $410,000 expenses · posted Oct 17, 2025

View → Q2

JAZZ PHARMACEUTICALS, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $370,000 expenses · posted Jul 18, 2025

View → Q1

JAZZ PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $380,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.